Excellent treatment outcomes in children younger than 18 months with stage 4 MYCN nonamplified neuroblastoma.
Conclusion: Patients younger than 18 months with stage 4 MYCN nonamplified neuroblastoma showed excellent outcomes, without significant late adverse effects, when treated with alternating cycles of CEDC and ICE, followed by surgery and differentiation therapy.
PMID: 29563945 [PubMed]
Source: Korean Journal of Pediatrics - Category: Pediatrics Tags: Korean J Pediatr Source Type: research
More News: Brain | Cancer & Oncology | Chemotherapy | Children | Liver | Neuroblastoma | Neurology | Neurosurgery | Pediatrics | Skin | Study | Toxicology | Urology & Nephrology